Pierre K Alexandre, Seungyoung Hwang, Kimberly B Roth, Joseph J Gallo, William W Eaton
{"title":"基于人群样本的医疗保险接受者索赔数据的抑郁症成本。","authors":"Pierre K Alexandre, Seungyoung Hwang, Kimberly B Roth, Joseph J Gallo, William W Eaton","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Many persons with depressive disorder are not treated and associated costs are not recorded.</p><p><strong>Aims of the study: </strong>To determine whether major depressive disorder (MDD) is associated with higher medical cost among Medicare recipients.</p><p><strong>Methods: </strong>Four waves of the Baltimore-Epidemiologic Catchment Area (Baltimore ECA) Study conducted between 1981 and 2004 were linked to Medicare claims data for the years 1999 to 2004 from the Centers for Medicare and Medicaid Services (CMS). Generalized linear models specified with a gamma distribution and log link function were used to examine direct medical care costs associated with MDD.</p><p><strong>Results: </strong>Medicare recipients with no history of MDD in either the ECA or CMS data had mean six-year medical costs of US $40,670, compared to $87,445 for Medicare recipients with MDD as recorded in CMS data and $43,583 for those with MDD as recorded in Baltimore-ECA data. Multivariable regressions found that compared to Medicare recipients with no history of depression, those with depression identified in the CMS data had significantly higher medical costs; about 1.87 times (95% confidence interval (CI) 1.32 to 2.67) higher. Medicare recipients with a history of depression identified in the ECA data were no more likely to have higher costs than were Medicare recipients with no history of depression (relative ratio 1.33, 95% CI 0.87 to 2.02).</p><p><strong>Discussion: </strong>Medicare recipients with a history of depression identified in claims data had significantly higher medical costs than recipients with no history of depression. However, no significant differences were found between Medicare recipients with depression in the community-based Baltimore ECA data and those with no history of depression. The results show that the source of diagnosis, in treatment versus survey data, produces differences in results as regards costs.</p><p><strong>Limitations: </strong>This study involved only Medicare recipients with claims data over the six years 1999 to 2004. Many of the ECA respondents were too young to qualify for Medicare.</p><p><strong>Implications for health policy: </strong>Depressive disorder involves substantial medical care costs. The findings provide information on the economic burden of depression, an important but often omitted dimension and perspective of the burden of mental illnesses.</p>","PeriodicalId":15909,"journal":{"name":"Journal of health and human services administration","volume":"39 1","pages":"72-94"},"PeriodicalIF":0.0000,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"COSTS OF DEPRESSION FROM CLAIMS DATA FOR MEDICARE RECIPIENTS IN A POPULATION-BASED SAMPLE.\",\"authors\":\"Pierre K Alexandre, Seungyoung Hwang, Kimberly B Roth, Joseph J Gallo, William W Eaton\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Many persons with depressive disorder are not treated and associated costs are not recorded.</p><p><strong>Aims of the study: </strong>To determine whether major depressive disorder (MDD) is associated with higher medical cost among Medicare recipients.</p><p><strong>Methods: </strong>Four waves of the Baltimore-Epidemiologic Catchment Area (Baltimore ECA) Study conducted between 1981 and 2004 were linked to Medicare claims data for the years 1999 to 2004 from the Centers for Medicare and Medicaid Services (CMS). Generalized linear models specified with a gamma distribution and log link function were used to examine direct medical care costs associated with MDD.</p><p><strong>Results: </strong>Medicare recipients with no history of MDD in either the ECA or CMS data had mean six-year medical costs of US $40,670, compared to $87,445 for Medicare recipients with MDD as recorded in CMS data and $43,583 for those with MDD as recorded in Baltimore-ECA data. Multivariable regressions found that compared to Medicare recipients with no history of depression, those with depression identified in the CMS data had significantly higher medical costs; about 1.87 times (95% confidence interval (CI) 1.32 to 2.67) higher. Medicare recipients with a history of depression identified in the ECA data were no more likely to have higher costs than were Medicare recipients with no history of depression (relative ratio 1.33, 95% CI 0.87 to 2.02).</p><p><strong>Discussion: </strong>Medicare recipients with a history of depression identified in claims data had significantly higher medical costs than recipients with no history of depression. However, no significant differences were found between Medicare recipients with depression in the community-based Baltimore ECA data and those with no history of depression. The results show that the source of diagnosis, in treatment versus survey data, produces differences in results as regards costs.</p><p><strong>Limitations: </strong>This study involved only Medicare recipients with claims data over the six years 1999 to 2004. Many of the ECA respondents were too young to qualify for Medicare.</p><p><strong>Implications for health policy: </strong>Depressive disorder involves substantial medical care costs. The findings provide information on the economic burden of depression, an important but often omitted dimension and perspective of the burden of mental illnesses.</p>\",\"PeriodicalId\":15909,\"journal\":{\"name\":\"Journal of health and human services administration\",\"volume\":\"39 1\",\"pages\":\"72-94\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of health and human services administration\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of health and human services administration","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
背景:许多抑郁症患者没有得到治疗,相关费用也没有记录。研究目的:确定重度抑郁症(MDD)是否与医疗保险接受者较高的医疗费用相关。方法:1981年至2004年间进行的巴尔的摩流行病学集水区(Baltimore ECA)研究的四波与1999年至2004年医疗保险和医疗补助服务中心(CMS)的医疗保险索赔数据相关联。使用gamma分布和对数链接函数指定的广义线性模型来检查与MDD相关的直接医疗保健费用。结果:在ECA或CMS数据中没有MDD病史的医疗保险受助人平均6年医疗费用为40,670美元,而在CMS数据中记录有MDD的医疗保险受助人为87,445美元,在巴尔的摩-ECA数据中记录有MDD的医疗保险受助人为43,583美元。多变量回归发现,与没有抑郁症病史的医疗保险接受者相比,CMS数据中确定的抑郁症患者的医疗费用明显更高;约为1.87倍(95%置信区间(CI) 1.32 ~ 2.67)。ECA数据中确定有抑郁史的医疗保险受助人并不比没有抑郁史的医疗保险受助人有更高的费用(相对比1.33,95% CI 0.87至2.02)。讨论:在索赔数据中确定有抑郁症病史的医疗保险受助人的医疗费用明显高于无抑郁症病史的受助人。然而,在以社区为基础的巴尔的摩ECA数据中,患有抑郁症的医疗保险接受者与没有抑郁症病史的人之间没有显著差异。结果表明,在治疗和调查数据方面,诊断来源在费用方面产生了差异。局限性:本研究仅涉及1999年至2004年6年间医疗保险受益人的索赔数据。许多ECA受访者都太年轻,没有资格享受医疗保险。对卫生政策的启示:抑郁症涉及大量的医疗费用。这些发现提供了有关抑郁症经济负担的信息,这是精神疾病负担的一个重要但经常被忽略的维度和视角。
COSTS OF DEPRESSION FROM CLAIMS DATA FOR MEDICARE RECIPIENTS IN A POPULATION-BASED SAMPLE.
Background: Many persons with depressive disorder are not treated and associated costs are not recorded.
Aims of the study: To determine whether major depressive disorder (MDD) is associated with higher medical cost among Medicare recipients.
Methods: Four waves of the Baltimore-Epidemiologic Catchment Area (Baltimore ECA) Study conducted between 1981 and 2004 were linked to Medicare claims data for the years 1999 to 2004 from the Centers for Medicare and Medicaid Services (CMS). Generalized linear models specified with a gamma distribution and log link function were used to examine direct medical care costs associated with MDD.
Results: Medicare recipients with no history of MDD in either the ECA or CMS data had mean six-year medical costs of US $40,670, compared to $87,445 for Medicare recipients with MDD as recorded in CMS data and $43,583 for those with MDD as recorded in Baltimore-ECA data. Multivariable regressions found that compared to Medicare recipients with no history of depression, those with depression identified in the CMS data had significantly higher medical costs; about 1.87 times (95% confidence interval (CI) 1.32 to 2.67) higher. Medicare recipients with a history of depression identified in the ECA data were no more likely to have higher costs than were Medicare recipients with no history of depression (relative ratio 1.33, 95% CI 0.87 to 2.02).
Discussion: Medicare recipients with a history of depression identified in claims data had significantly higher medical costs than recipients with no history of depression. However, no significant differences were found between Medicare recipients with depression in the community-based Baltimore ECA data and those with no history of depression. The results show that the source of diagnosis, in treatment versus survey data, produces differences in results as regards costs.
Limitations: This study involved only Medicare recipients with claims data over the six years 1999 to 2004. Many of the ECA respondents were too young to qualify for Medicare.
Implications for health policy: Depressive disorder involves substantial medical care costs. The findings provide information on the economic burden of depression, an important but often omitted dimension and perspective of the burden of mental illnesses.
期刊介绍:
The Journal of Health and Human Services Administration (JHHSA) began publication in 1978 as the Journal of Health and Human Resources Administration. It is a blind-refereed journal dedicated to publishing articles, symposia and book reviews in all areas of health, hospital and welfare administration and management.